| Ticker | Action | Number of Shares Bought/Sold | Value of Shares Added/Sold | Average Price paid for previous share BUYs |
|---|
| DVA - DaVita HealthCare Partners Inc | SELL | -40 @ USD 117.94 | USD -4,718 | The ETF sold 40 shares of DVA on 2025-12-16. The shares were previously bought for an average price of USD 139.909. The DaVita HealthCare Partners Inc shares were sold for -15.7% lower than average price of previous purchases. This resulted in an overall loss of USD 879 The average price that the ETF previously sold DVA share for is USD 142.456 which is higher than the selling price of USD 117.94 on 2025-12-16. |
| HSIC - Henry Schein Inc | SELL | -116 @ USD 77.05 | USD -8,938 | The ETF sold 116 shares of HSIC on 2025-12-16. The shares were previously bought for an average price of USD 71.3299. The Henry Schein Inc shares were sold for 8.0% higher than average price of previous purchases. This sale made a profit of USD 664 The average price that the ETF previously sold HSIC share for is USD 69.7835 so the ETF has sold 116 shares on 2025-12-16 at a higher price than the previous selling average. |
| MOH - MOH | SELL | -60 @ USD 160.88 | USD -9,653 | The ETF sold 60 shares of MOH on 2025-12-16. The shares were previously bought for an average price of USD 230.472. The MOH shares were sold for -30.2% lower than average price of previous purchases. This resulted in an overall loss of USD 4,176 The average price that the ETF previously sold MOH share for is USD 283.028 which is higher than the selling price of USD 160.88 on 2025-12-16. |
| MOH - LVMH Moët Hennessy - Louis Vuitton Société Européenne | SELL | -60 @ USD 160.88 | USD -9,653 | The ETF sold 60 shares of MOH on 2025-12-16. The shares were previously bought for an average price of USD 230.472. The LVMH Moët Hennessy - Louis Vuitton Société Européenne shares were sold for -30.2% lower than average price of previous purchases. This resulted in an overall loss of USD 4,176 The average price that the ETF previously sold MOH share for is USD 283.028 which is higher than the selling price of USD 160.88 on 2025-12-16. |
| TECH - Bio-Techne Corp | SELL | -174 @ USD 57.44 | USD -9,995 | The ETF sold 174 shares of TECH on 2025-12-16. The shares were previously bought for an average price of USD 60.5236. The Bio-Techne Corp shares were sold for -5.1% lower than average price of previous purchases. This resulted in an overall loss of USD 537 The average price that the ETF previously sold TECH share for is USD 65.765 which is higher than the selling price of USD 57.44 on 2025-12-16. |
| CRL - Creightons Plc | SELL | -54 @ USD 195.22 | USD -10,542 | The ETF sold 54 shares of CRL on 2025-12-16. The shares were previously bought for an average price of USD 169.292. The Creightons Plc shares were sold for 15.3% higher than average price of previous purchases. This sale made a profit of USD 1,400 The average price that the ETF previously sold CRL share for is USD 174.835 so the ETF has sold 54 shares on 2025-12-16 at a higher price than the previous selling average. |
| BAX - Baxter International Inc | SELL | -576 @ USD 19.05 | USD -10,973 | The ETF sold 576 shares of BAX on 2025-12-16. The shares were previously bought for an average price of USD 27.0166. The Baxter International Inc shares were sold for -29.5% lower than average price of previous purchases. This resulted in an overall loss of USD 4,589 The average price that the ETF previously sold BAX share for is USD 30.2246 which is higher than the selling price of USD 19.05 on 2025-12-16. |
| MRNA - Moderna Inc | SELL | -384 @ USD 29.89 | USD -11,478 | The ETF sold 384 shares of MRNA on 2025-12-16. The shares were previously bought for an average price of USD 30.1503. The Moderna Inc shares were sold for -0.9% lower than average price of previous purchases. This resulted in an overall loss of USD 100 The average price that the ETF previously sold MRNA share for is USD 36.9936 which is higher than the selling price of USD 29.89 on 2025-12-16. |
| ALGN - Align Technology Inc | SELL | -74 @ USD 162.89 | USD -12,054 | The ETF sold 74 shares of ALGN on 2025-12-16. The shares were previously bought for an average price of USD 166.795. The Align Technology Inc shares were sold for -2.3% lower than average price of previous purchases. This resulted in an overall loss of USD 289 The average price that the ETF previously sold ALGN share for is USD 198.292 which is higher than the selling price of USD 162.89 on 2025-12-16. |
| RVTY - Revvity Inc. | SELL | -132 @ USD 96.27 | USD -12,708 | The ETF sold 132 shares of RVTY on 2025-12-16. The shares were previously bought for an average price of USD 102.676. The Revvity Inc. shares were sold for -6.2% lower than average price of previous purchases. This resulted in an overall loss of USD 846 The average price that the ETF previously sold RVTY share for is USD 107.484 which is higher than the selling price of USD 96.27 on 2025-12-16. |
| SOLV - Solventum Corp. | SELL | -164 @ USD 80.59 | USD -13,217 | The ETF sold 164 shares of SOLV on 2025-12-16. The shares were previously bought for an average price of USD 74.1678. The Solventum Corp. shares were sold for 8.7% higher than average price of previous purchases. This sale made a profit of USD 1,053 The average price that the ETF previously sold SOLV share for is USD 72.1047 so the ETF has sold 164 shares on 2025-12-16 at a higher price than the previous selling average. |
| UHS - Universal Health Services Inc | SELL | -62 @ USD 222.64 | USD -13,804 | The ETF sold 62 shares of UHS on 2025-12-16. The shares were previously bought for an average price of USD 197.748. The Universal Health Services Inc shares were sold for 12.6% higher than average price of previous purchases. This sale made a profit of USD 1,543 The average price that the ETF previously sold UHS share for is USD 194.611 so the ETF has sold 62 shares on 2025-12-16 at a higher price than the previous selling average. |
| VTRS - Viatris Inc | SELL | -1,290 @ USD 11.46 | USD -14,783 | The ETF sold 1290 shares of VTRS on 2025-12-16. The shares were previously bought for an average price of USD 10.4179. The Viatris Inc shares were sold for 10.0% higher than average price of previous purchases. This sale made a profit of USD 1,344 The average price that the ETF previously sold VTRS share for is USD 11.1368 so the ETF has sold 1290 shares on 2025-12-16 at a higher price than the previous selling average. |
| INCY - Incyte Corporation | SELL | -184 @ USD 97.03 | USD -17,854 | The ETF sold 184 shares of INCY on 2025-12-16. The shares were previously bought for an average price of USD 81.0742. The Incyte Corporation shares were sold for 19.7% higher than average price of previous purchases. This sale made a profit of USD 2,936 The average price that the ETF previously sold INCY share for is USD 75.4894 so the ETF has sold 184 shares on 2025-12-16 at a higher price than the previous selling average. |
| COO - The Cooper Companies, Inc. Common Stock | SELL | -224 @ USD 81.04 | USD -18,153 | The ETF sold 224 shares of COO on 2025-12-16. The shares were previously bought for an average price of USD 80.7605. The The Cooper Companies, Inc. Common Stock shares were sold for 0.3% higher than average price of previous purchases. This sale made a profit of USD 63 The average price that the ETF previously sold COO share for is USD 88.5039 which is higher than the selling price of USD 81.04 on 2025-12-16. |
| HOLX - Hologic Inc | SELL | -248 @ USD 75.02 | USD -18,605 | The ETF sold 248 shares of HOLX on 2025-12-16. The shares were previously bought for an average price of USD 68.843. The Hologic Inc shares were sold for 9.0% higher than average price of previous purchases. This sale made a profit of USD 1,532 The average price that the ETF previously sold HOLX share for is USD 71.0011 so the ETF has sold 248 shares on 2025-12-16 at a higher price than the previous selling average. |
| ZBH - Zimmer Biomet Holdings Inc | SELL | -222 @ USD 90.91 | USD -20,182 | The ETF sold 222 shares of ZBH on 2025-12-16. The shares were previously bought for an average price of USD 101.141. The Zimmer Biomet Holdings Inc shares were sold for -10.1% lower than average price of previous purchases. This resulted in an overall loss of USD 2,271 The average price that the ETF previously sold ZBH share for is USD 103.456 which is higher than the selling price of USD 90.91 on 2025-12-16. |
| CNC - Concurrent Technologies Plc | SELL | -522 @ USD 38.97 | USD -20,342 | The ETF sold 522 shares of CNC on 2025-12-16. The shares were previously bought for an average price of USD 46.3603. The Concurrent Technologies Plc shares were sold for -15.9% lower than average price of previous purchases. This resulted in an overall loss of USD 3,858 The average price that the ETF previously sold CNC share for is USD 52.3944 which is higher than the selling price of USD 38.97 on 2025-12-16. |
| WST - West Pharmaceutical Services Inc | SELL | -78 @ USD 266.44 | USD -20,782 | The ETF sold 78 shares of WST on 2025-12-16. The shares were previously bought for an average price of USD 258.129. The West Pharmaceutical Services Inc shares were sold for 3.2% higher than average price of previous purchases. This sale made a profit of USD 648 The average price that the ETF previously sold WST share for is USD 285.092 which is higher than the selling price of USD 266.44 on 2025-12-16. |
| DGX - Quest Diagnostics Incorporated | SELL | -124 @ USD 178.66 | USD -22,154 | The ETF sold 124 shares of DGX on 2025-12-16. The shares were previously bought for an average price of USD 175.624. The Quest Diagnostics Incorporated shares were sold for 1.7% higher than average price of previous purchases. This sale made a profit of USD 376 The average price that the ETF previously sold DGX share for is USD 165.81 so the ETF has sold 124 shares on 2025-12-16 at a higher price than the previous selling average. |
| PODD - Insulet Corporation | SELL | -78 @ USD 288.73 | USD -22,521 | The ETF sold 78 shares of PODD on 2025-12-16. The shares were previously bought for an average price of USD 295.758. The Insulet Corporation shares were sold for -2.4% lower than average price of previous purchases. This resulted in an overall loss of USD 548 The average price that the ETF previously sold PODD share for is USD 277.537 so the ETF has sold 78 shares on 2025-12-16 at a higher price than the previous selling average. |
| LH - Laboratory Corporation of America Holdings | SELL | -92 @ USD 258.11 | USD -23,746 | The ETF sold 92 shares of LH on 2025-12-16. The shares were previously bought for an average price of USD 257.396. The Laboratory Corporation of America Holdings shares were sold for 0.3% higher than average price of previous purchases. This sale made a profit of USD 66 The average price that the ETF previously sold LH share for is USD 243.651 so the ETF has sold 92 shares on 2025-12-16 at a higher price than the previous selling average. |
| WAT - Waters Corporation | SELL | -66 @ USD 378.53 | USD -24,983 | The ETF sold 66 shares of WAT on 2025-12-16. The shares were previously bought for an average price of USD 353.64. The Waters Corporation shares were sold for 7.0% higher than average price of previous purchases. This sale made a profit of USD 1,643 The average price that the ETF previously sold WAT share for is USD 365.283 so the ETF has sold 66 shares on 2025-12-16 at a higher price than the previous selling average. |
| WAT - MULETFWATIMETFP | SELL | -66 @ USD 378.53 | USD -24,983 | The ETF sold 66 shares of WAT on 2025-12-16. The shares were previously bought for an average price of USD 353.64. The MULETFWATIMETFP shares were sold for 7.0% higher than average price of previous purchases. This sale made a profit of USD 1,643 The average price that the ETF previously sold WAT share for is USD 365.283 so the ETF has sold 66 shares on 2025-12-16 at a higher price than the previous selling average. |
| STE - STERIS plc | SELL | -108 @ USD 253.03 | USD -27,327 | The ETF sold 108 shares of STE on 2025-12-16. The shares were previously bought for an average price of USD 236.968. The STERIS plc shares were sold for 6.8% higher than average price of previous purchases. This sale made a profit of USD 1,735 The average price that the ETF previously sold STE share for is USD 224.468 so the ETF has sold 108 shares on 2025-12-16 at a higher price than the previous selling average. |
| BIIB - Biogen Inc | SELL | -162 @ USD 171.5 | USD -27,783 | The ETF sold 162 shares of BIIB on 2025-12-16. The shares were previously bought for an average price of USD 148.108. The Biogen Inc shares were sold for 15.8% higher than average price of previous purchases. This sale made a profit of USD 3,790 The average price that the ETF previously sold BIIB share for is USD 153.306 so the ETF has sold 162 shares on 2025-12-16 at a higher price than the previous selling average. |
| DXCM - DexCom Inc | SELL | -438 @ USD 66.37 | USD -29,070 | The ETF sold 438 shares of DXCM on 2025-12-16. The shares were previously bought for an average price of USD 73.9049. The DexCom Inc shares were sold for -10.2% lower than average price of previous purchases. This resulted in an overall loss of USD 3,300 The average price that the ETF previously sold DXCM share for is USD 76.0433 which is higher than the selling price of USD 66.37 on 2025-12-16. |
| MTD - Mettler-Toledo International Inc | SELL | -22 @ USD 1386.45 | USD -30,502 | The ETF sold 22 shares of MTD on 2025-12-16. The shares were previously bought for an average price of USD 1302.4. The Mettler-Toledo International Inc shares were sold for 6.5% higher than average price of previous purchases. This sale made a profit of USD 1,849 The average price that the ETF previously sold MTD share for is USD 1252.48 so the ETF has sold 22 shares on 2025-12-16 at a higher price than the previous selling average. |
| MTD - AMUNDI EUR GOV 710 | SELL | -22 @ USD 1386.45 | USD -30,502 | The ETF sold 22 shares of MTD on 2025-12-16. The shares were previously bought for an average price of USD 1302.4. The AMUNDI EUR GOV 710 shares were sold for 6.5% higher than average price of previous purchases. This sale made a profit of USD 1,849 The average price that the ETF previously sold MTD share for is USD 1252.48 so the ETF has sold 22 shares on 2025-12-16 at a higher price than the previous selling average. |
| HUM - Hummingbird Resources PLC | SELL | -132 @ USD 258.16 | USD -34,077 | The ETF sold 132 shares of HUM on 2025-12-16. The shares were previously bought for an average price of USD 265.559. The Hummingbird Resources PLC shares were sold for -2.8% lower than average price of previous purchases. This resulted in an overall loss of USD 977 The average price that the ETF previously sold HUM share for is USD 267.055 which is higher than the selling price of USD 258.16 on 2025-12-16. |
| HUM - Humana Inc | SELL | -132 @ USD 258.16 | USD -34,077 | The ETF sold 132 shares of HUM on 2025-12-16. The shares were previously bought for an average price of USD 265.559. The Humana Inc shares were sold for -2.8% lower than average price of previous purchases. This resulted in an overall loss of USD 977 The average price that the ETF previously sold HUM share for is USD 267.055 which is higher than the selling price of USD 258.16 on 2025-12-16. |
| RMD - ResMed Inc | SELL | -162 @ USD 247.34 | USD -40,069 | The ETF sold 162 shares of RMD on 2025-12-16. The shares were previously bought for an average price of USD 251.659. The ResMed Inc shares were sold for -1.7% lower than average price of previous purchases. This resulted in an overall loss of USD 700 The average price that the ETF previously sold RMD share for is USD 244.677 so the ETF has sold 162 shares on 2025-12-16 at a higher price than the previous selling average. |
| GEHC - GE HealthCare Technologies Inc. | SELL | -506 @ USD 82.25 | USD -41,619 | The ETF sold 506 shares of GEHC on 2025-12-16. The shares were previously bought for an average price of USD 79.4406. The GE HealthCare Technologies Inc. shares were sold for 3.5% higher than average price of previous purchases. This sale made a profit of USD 1,422 The average price that the ETF previously sold GEHC share for is USD 79.2118 so the ETF has sold 506 shares on 2025-12-16 at a higher price than the previous selling average. |
| IQV - IQVIA Holdings Inc | SELL | -188 @ USD 221.68 | USD -41,676 | The ETF sold 188 shares of IQV on 2025-12-16. The shares were previously bought for an average price of USD 196.033. The IQVIA Holdings Inc shares were sold for 13.1% higher than average price of previous purchases. This sale made a profit of USD 4,822 The average price that the ETF previously sold IQV share for is USD 191.547 so the ETF has sold 188 shares on 2025-12-16 at a higher price than the previous selling average. |
| A - Agilent Technologies Inc | SELL | -314 @ USD 139.19 | USD -43,706 | The ETF sold 314 shares of A on 2025-12-16. The shares were previously bought for an average price of USD 131.363. The Agilent Technologies Inc shares were sold for 6.0% higher than average price of previous purchases. This sale made a profit of USD 2,458 The average price that the ETF previously sold A share for is USD 131.73 so the ETF has sold 314 shares on 2025-12-16 at a higher price than the previous selling average. |
| CAH - Cardinal Health Inc | SELL | -262 @ USD 197.89 | USD -51,847 | The ETF sold 262 shares of CAH on 2025-12-16. The shares were previously bought for an average price of USD 154.491. The Cardinal Health Inc shares were sold for 28.1% higher than average price of previous purchases. This sale made a profit of USD 11,371 The average price that the ETF previously sold CAH share for is USD 139.784 so the ETF has sold 262 shares on 2025-12-16 at a higher price than the previous selling average. |
| EW - Edwards Lifesciences Corp | SELL | -652 @ USD 85.32 | USD -55,629 | The ETF sold 652 shares of EW on 2025-12-16. The shares were previously bought for an average price of USD 76.0054. The Edwards Lifesciences Corp shares were sold for 12.3% higher than average price of previous purchases. This sale made a profit of USD 6,073 The average price that the ETF previously sold EW share for is USD 73.028 so the ETF has sold 652 shares on 2025-12-16 at a higher price than the previous selling average. |
| ZTS - Zoetis Inc | SELL | -492 @ USD 123.23 | USD -60,629 | The ETF sold 492 shares of ZTS on 2025-12-16. The shares were previously bought for an average price of USD 150.818. The Zoetis Inc shares were sold for -18.3% lower than average price of previous purchases. This resulted in an overall loss of USD 13,573 The average price that the ETF previously sold ZTS share for is USD 163.579 which is higher than the selling price of USD 123.23 on 2025-12-16. |
| IDXX - IDEXX Laboratories Inc | SELL | -88 @ USD 693.18 | USD -61,000 | The ETF sold 88 shares of IDXX on 2025-12-16. The shares were previously bought for an average price of USD 569.15. The IDEXX Laboratories Inc shares were sold for 21.8% higher than average price of previous purchases. This sale made a profit of USD 10,915 The average price that the ETF previously sold IDXX share for is USD 484.936 so the ETF has sold 88 shares on 2025-12-16 at a higher price than the previous selling average. |
| BDX - Becton Dickinson and Company | SELL | -316 @ USD 196.39 | USD -62,059 | The ETF sold 316 shares of BDX on 2025-12-16. The shares were previously bought for an average price of USD 204.877. The Becton Dickinson and Company shares were sold for -4.1% lower than average price of previous purchases. This resulted in an overall loss of USD 2,682 The average price that the ETF previously sold BDX share for is USD 208.997 which is higher than the selling price of USD 196.39 on 2025-12-16. |
| COR - Cencora Inc. | SELL | -214 @ USD 341.72 | USD -73,128 | The ETF sold 214 shares of COR on 2025-12-16. The shares were previously bought for an average price of USD 302.142. The Cencora Inc. shares were sold for 13.1% higher than average price of previous purchases. This sale made a profit of USD 8,470 The average price that the ETF previously sold COR share for is USD 270.403 so the ETF has sold 214 shares on 2025-12-16 at a higher price than the previous selling average. |
| CI - Cigna Corp | SELL | -294 @ USD 276.11 | USD -81,176 | The ETF sold 294 shares of CI on 2025-12-16. The shares were previously bought for an average price of USD 298.372. The Cigna Corp shares were sold for -7.5% lower than average price of previous purchases. This resulted in an overall loss of USD 6,545 The average price that the ETF previously sold CI share for is USD 307.942 which is higher than the selling price of USD 276.11 on 2025-12-16. |
| REGN - Regeneron Pharmaceuticals Inc | SELL | -112 @ USD 746.36 | USD -83,592 | The ETF sold 112 shares of REGN on 2025-12-16. The shares were previously bought for an average price of USD 662.79. The Regeneron Pharmaceuticals Inc shares were sold for 12.6% higher than average price of previous purchases. This sale made a profit of USD 9,360 The average price that the ETF previously sold REGN share for is USD 690.745 so the ETF has sold 112 shares on 2025-12-16 at a higher price than the previous selling average. |
| HCA - HCA Holdings Inc | SELL | -180 @ USD 469.79 | USD -84,562 | The ETF sold 180 shares of HCA on 2025-12-16. The shares were previously bought for an average price of USD 393.849. The HCA Holdings Inc shares were sold for 19.3% higher than average price of previous purchases. This sale made a profit of USD 13,669 The average price that the ETF previously sold HCA share for is USD 362.591 so the ETF has sold 180 shares on 2025-12-16 at a higher price than the previous selling average. |
| ELV - Elevance Health Inc | SELL | -248 @ USD 351.9 | USD -87,271 | The ETF sold 248 shares of ELV on 2025-12-16. The shares were previously bought for an average price of USD 365.457. The Elevance Health Inc shares were sold for -3.7% lower than average price of previous purchases. This resulted in an overall loss of USD 3,362 The average price that the ETF previously sold ELV share for is USD 384.744 which is higher than the selling price of USD 351.9 on 2025-12-16. |
| ELV - Elevance Health Inc | SELL | -248 @ USD 351.9 | USD -87,271 | The ETF sold 248 shares of ELV on 2025-12-16. The shares were previously bought for an average price of USD 365.457. The Elevance Health Inc shares were sold for -3.7% lower than average price of previous purchases. This resulted in an overall loss of USD 3,362 The average price that the ETF previously sold ELV share for is USD 384.744 which is higher than the selling price of USD 351.9 on 2025-12-16. |
| CVS - CVS Health Corp | SELL | -1,398 @ USD 78.29 | USD -109,449 | The ETF sold 1398 shares of CVS on 2025-12-16. The shares were previously bought for an average price of USD 70.0444. The CVS Health Corp shares were sold for 11.8% higher than average price of previous purchases. This sale made a profit of USD 11,527 The average price that the ETF previously sold CVS share for is USD 60.277 so the ETF has sold 1398 shares on 2025-12-16 at a higher price than the previous selling average. |
| MCK - McKesson Corporation | SELL | -136 @ USD 809.96 | USD -110,155 | The ETF sold 136 shares of MCK on 2025-12-16. The shares were previously bought for an average price of USD 711.566. The McKesson Corporation shares were sold for 13.8% higher than average price of previous purchases. This sale made a profit of USD 13,382 The average price that the ETF previously sold MCK share for is USD 652.938 so the ETF has sold 136 shares on 2025-12-16 at a higher price than the previous selling average. |
| BMY - Bloomsbury Publishing Plc | SELL | -2,242 @ USD 54.23 | USD -121,584 | The ETF sold 2242 shares of BMY on 2025-12-16. The shares were previously bought for an average price of USD 51.7826. The Bloomsbury Publishing Plc shares were sold for 4.7% higher than average price of previous purchases. This sale made a profit of USD 5,487 The average price that the ETF previously sold BMY share for is USD 53.413 so the ETF has sold 2242 shares on 2025-12-16 at a higher price than the previous selling average. |
| VRTX - Vertex Pharmaceuticals Inc | SELL | -282 @ USD 454.96 | USD -128,299 | The ETF sold 282 shares of VRTX on 2025-12-16. The shares were previously bought for an average price of USD 442.691. The Vertex Pharmaceuticals Inc shares were sold for 2.8% higher than average price of previous purchases. This sale made a profit of USD 3,460 The average price that the ETF previously sold VRTX share for is USD 457.439 which is higher than the selling price of USD 454.96 on 2025-12-16. |
| SYK - Stryker Corporation | SELL | -378 @ USD 351.69 | USD -132,939 | The ETF sold 378 shares of SYK on 2025-12-16. The shares were previously bought for an average price of USD 373.859. The Stryker Corporation shares were sold for -5.9% lower than average price of previous purchases. This resulted in an overall loss of USD 8,380 The average price that the ETF previously sold SYK share for is USD 376.479 which is higher than the selling price of USD 351.69 on 2025-12-16. |
| MDT - Medtronic PLC | SELL | -1,412 @ USD 97.72 | USD -137,981 | The ETF sold 1412 shares of MDT on 2025-12-16. The shares were previously bought for an average price of USD 92.1519. The Medtronic PLC shares were sold for 6.0% higher than average price of previous purchases. This sale made a profit of USD 7,862 The average price that the ETF previously sold MDT share for is USD 87.4889 so the ETF has sold 1412 shares on 2025-12-16 at a higher price than the previous selling average. |
| BSX - Boston Scientific Corporation | SELL | -1,632 @ USD 92.95 | USD -151,694 | The ETF sold 1632 shares of BSX on 2025-12-16. The shares were previously bought for an average price of USD 99.2087. The Boston Scientific Corporation shares were sold for -6.3% lower than average price of previous purchases. This resulted in an overall loss of USD 10,214 The average price that the ETF previously sold BSX share for is USD 94.3618 which is higher than the selling price of USD 92.95 on 2025-12-16. |
| BSX - MULSTRXSSXIMETFP | SELL | -1,632 @ USD 92.95 | USD -151,694 | The ETF sold 1632 shares of BSX on 2025-12-16. The shares were previously bought for an average price of USD 99.2087. The MULSTRXSSXIMETFP shares were sold for -6.3% lower than average price of previous purchases. This resulted in an overall loss of USD 10,214 The average price that the ETF previously sold BSX share for is USD 94.3618 which is higher than the selling price of USD 92.95 on 2025-12-16. |
| DHR - Danaher Corporation | SELL | -700 @ USD 224.7 | USD -157,290 | The ETF sold 700 shares of DHR on 2025-12-16. The shares were previously bought for an average price of USD 214.675. The Danaher Corporation shares were sold for 4.7% higher than average price of previous purchases. This sale made a profit of USD 7,017 The average price that the ETF previously sold DHR share for is USD 223.374 so the ETF has sold 700 shares on 2025-12-16 at a higher price than the previous selling average. |
| DHR - Danaher Corporation | SELL | -700 @ USD 224.7 | USD -157,290 | The ETF sold 700 shares of DHR on 2025-12-16. The shares were previously bought for an average price of USD 214.675. The Danaher Corporation shares were sold for 4.7% higher than average price of previous purchases. This sale made a profit of USD 7,017 The average price that the ETF previously sold DHR share for is USD 223.374 so the ETF has sold 700 shares on 2025-12-16 at a higher price than the previous selling average. |
| PFE - Pfizer Inc | SELL | -6,268 @ USD 25.53 | USD -160,022 | The ETF sold 6268 shares of PFE on 2025-12-16. The shares were previously bought for an average price of USD 25.3863. The Pfizer Inc shares were sold for 0.6% higher than average price of previous purchases. This sale made a profit of USD 901 The average price that the ETF previously sold PFE share for is USD 25.5293 so the ETF has sold 6268 shares on 2025-12-16 at a higher price than the previous selling average. |
| GILD - Guild Esports Plc | SELL | -1,368 @ USD 118.78 | USD -162,491 | The ETF sold 1368 shares of GILD on 2025-12-16. The shares were previously bought for an average price of USD 111.763. The Guild Esports Plc shares were sold for 6.3% higher than average price of previous purchases. This sale made a profit of USD 9,599 The average price that the ETF previously sold GILD share for is USD 101.194 so the ETF has sold 1368 shares on 2025-12-16 at a higher price than the previous selling average. |
| AMGN - Amgen Inc | SELL | -592 @ USD 326.74 | USD -193,430 | The ETF sold 592 shares of AMGN on 2025-12-16. The shares were previously bought for an average price of USD 304.329. The Amgen Inc shares were sold for 7.4% higher than average price of previous purchases. This sale made a profit of USD 13,267 The average price that the ETF previously sold AMGN share for is USD 292.88 so the ETF has sold 592 shares on 2025-12-16 at a higher price than the previous selling average. |
| ISRG - Intuitive Surgical Inc | SELL | -394 @ USD 554.58 | USD -218,505 | The ETF sold 394 shares of ISRG on 2025-12-16. The shares were previously bought for an average price of USD 521.681. The Intuitive Surgical Inc shares were sold for 6.3% higher than average price of previous purchases. This sale made a profit of USD 12,962 The average price that the ETF previously sold ISRG share for is USD 531.434 so the ETF has sold 394 shares on 2025-12-16 at a higher price than the previous selling average. |
| TMO - Time Out Group plc | SELL | -414 @ USD 570.16 | USD -236,046 | The ETF sold 414 shares of TMO on 2025-12-16. The shares were previously bought for an average price of USD 521.892. The Time Out Group plc shares were sold for 9.2% higher than average price of previous purchases. This sale made a profit of USD 19,983 The average price that the ETF previously sold TMO share for is USD 505.145 so the ETF has sold 414 shares on 2025-12-16 at a higher price than the previous selling average. |
| ABT - Abbott Laboratories | SELL | -1,914 @ USD 126.86 | USD -242,810 | The ETF sold 1914 shares of ABT on 2025-12-16. The shares were previously bought for an average price of USD 128.684. The Abbott Laboratories shares were sold for -1.4% lower than average price of previous purchases. This resulted in an overall loss of USD 3,491 The average price that the ETF previously sold ABT share for is USD 122.163 so the ETF has sold 1914 shares on 2025-12-16 at a higher price than the previous selling average. |
| MRK - Marks Electrical Group PLC | SELL | -2,748 @ USD 98.27 | USD -270,046 | The ETF sold 2748 shares of MRK on 2025-12-16. The shares were previously bought for an average price of USD 90.1809. The Marks Electrical Group PLC shares were sold for 9.0% higher than average price of previous purchases. This sale made a profit of USD 22,229 The average price that the ETF previously sold MRK share for is USD 94.2689 so the ETF has sold 2748 shares on 2025-12-16 at a higher price than the previous selling average. |
| MRK - Merck & Company Inc | SELL | -2,748 @ USD 98.27 | USD -270,046 | The ETF sold 2748 shares of MRK on 2025-12-16. The shares were previously bought for an average price of USD 90.1809. The Merck & Company Inc shares were sold for 9.0% higher than average price of previous purchases. This sale made a profit of USD 22,229 The average price that the ETF previously sold MRK share for is USD 94.2689 so the ETF has sold 2748 shares on 2025-12-16 at a higher price than the previous selling average. |
| UNH - UnitedHealth Group Incorporated | SELL | -994 @ USD 334.2 | USD -332,195 | The ETF sold 994 shares of UNH on 2025-12-16. The shares were previously bought for an average price of USD 407.683. The UnitedHealth Group Incorporated shares were sold for -18.0% lower than average price of previous purchases. This resulted in an overall loss of USD 73,042 The average price that the ETF previously sold UNH share for is USD 474.268 which is higher than the selling price of USD 334.2 on 2025-12-16. |
| ABBV - AbbVie Inc | SELL | -1,942 @ USD 223.67 | USD -434,367 | The ETF sold 1942 shares of ABBV on 2025-12-16. The shares were previously bought for an average price of USD 206.893. The AbbVie Inc shares were sold for 8.1% higher than average price of previous purchases. This sale made a profit of USD 32,581 The average price that the ETF previously sold ABBV share for is USD 191.541 so the ETF has sold 1942 shares on 2025-12-16 at a higher price than the previous selling average. |
| JNJ - Johnson & Johnson | SELL | -2,646 @ USD 209.3 | USD -553,808 | The ETF sold 2646 shares of JNJ on 2025-12-16. The shares were previously bought for an average price of USD 174.951. The Johnson & Johnson shares were sold for 19.6% higher than average price of previous purchases. This sale made a profit of USD 90,887 The average price that the ETF previously sold JNJ share for is USD 159.264 so the ETF has sold 2646 shares on 2025-12-16 at a higher price than the previous selling average. |
| LLY - Eli Lilly and Company | SELL | -874 @ USD 1054.29 | USD -921,449 | The ETF sold 874 shares of LLY on 2025-12-16. The shares were previously bought for an average price of USD 848.103. The Eli Lilly and Company shares were sold for 24.3% higher than average price of previous purchases. This sale made a profit of USD 180,207 The average price that the ETF previously sold LLY share for is USD 813.79 so the ETF has sold 874 shares on 2025-12-16 at a higher price than the previous selling average. |